STAT+: FDA unveils rules for bespoke gene therapies, pred...
The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.
What’s Happening
Breaking it down: The FDA expects a flood of applications for a new “plausible mechanism pathway” for approval of bespoke gene-editing treatments.
More details are expected to emerge soon.
Why This Matters
This is the kind of health news that affects everyday decisions.
Health experts are weighing in on what this means for people.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Sound off in the comments.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction